Fresenius SE KGaA (XTER:FRE) Valuation Rank


XTER:FRE Fresenius SE & Co KGaA XTER:FRE
67 GF Score
Price €40.07
GF Value €36.55
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Fresenius SE KGaA Valuation Rank Related Terms

XTER:FRE
67GF Score
Fresenius SE & Co KGaA XTER:FRE
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of €40.07 is trading 9.6% above its estimated GF Value™ of €36.55. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XTER:FRE:

  • Valuation Rank:
  • GF Value™: €36.55 vs. price of €40.07 (9.6% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score

Get the complete analysis for XTER:FRE

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.07
Price
€36.55
GF Value